MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with...

To assess the value of magnetic resonance (MR) imaging parameters as surrogate markers of stroke duration.

The study was approved by the Ethics Committee of Ile de France III and was found to conform to generally accepted scientific principles and ethical standards. The authors studied 130 patients with acute stroke of known onset time who underwent 1.5-T MR imaging within 12 hours of the onset of stroke symptoms. Fluid-attenuated inversion recovery (FLAIR), diffusion-weighted (DW) imaging, and apparent diffusion coefficient (ADC) ratios were computed by using three-dimensional regions of interest to outline signal intensity changes on DW images and then projecting them onto the contralateral hemisphere. Imaging ratios in 63 patients who underwent imaging 0-3 hours after symptom onset were compared with those in 67 patients who underwent imaging more than 3 hours after onset by using the Student t test and receiver operating characteristic curves. The accuracy (sensitivity, specificity, and 95% confidence intervals [CIs]) of lesion visibility on FLAIR images in the prediction of a stroke onset time of less than 3 hours was assessed by two independent observers.

Differences in imaging ratios between patients imaged 0-3 hours after symptom onset and those imaged more than 3 hours after onset were statistically significant (P < .001). The FLAIR ratio showed a positive correlation with the time from symptom onset (Pearson correlation coefficient, 0.63). Receiver operating characteristic curves indicated that the FLAIR ratio could reliably identify patients imaged 0-3 hours after symptom onset, reaching 90% sensitivity (95% CI: 83%, 98%) and 93% specificity (95% CI: 86%, 99%) when using a 7% cutoff. Stroke imaged within 3 hours could also be identified by means of visual inspection of FLAIR and DW MR images, with 94% sensitivity (95% CI: 88%, 100%) and 97% specificity (95% CI: 93%, 101%).

Signal intensity changes on 1.5-T FLAIR MR images can be used as a surrogate marker of stroke age, either qualitatively or quantitatively. This suggests that MR imaging might be used as a "clock" for determining stroke age in patients with an unknown onset time, potentially increasing the number of patients who are eligible for thrombolysis.